A new preliminary study shows a single 200 mL dose of convalescent plasma (CP) from COVID-19 patients who recently recovered shortened the duration of symptoms, improved oxygen levels and increased the clearance of the virus in patients who were still suffering from the disease. “One dose of convalescent plasma with a high concentration of neutralizing antibodies can rapidly reduce the viral load and tends to improve clinical outcomes”.
You may also like
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak
May 12, 2020
The landscape of host genetic factors involved in infection to common viruses and SARS-CoV-2
Selection of viral variants during persistent infection of insectivorous bat cells with Coronavirus
May 7, 2020